The Cost of Cancer Drugs

The cost of cancer drugs, profiting and profiteering in the pharmaceutical business This weeks podcast examines several connected topics. My friend Brett Newcomb and I begin by discussing a recent article involving a letter sent by over a hundred Cancer specialists to the pharmaceutical industry chastising them for charging to much for Cancer drugs. In […]